ERBB2 and breast carcinoma: In estrogen receptor-negative human breast carcinoma cells usually overexpressing ErbB2, it was demonstrated that the addition of EGF induced the translocation of Akt and CaM to the plasma membrane, where the activation of Akt occurs.